Mast Cell Activation Syndrome MCAS Belgium 2025: NF-kB Mast Cells, Histamine & Ginger

DIRECT ANSWER

Mast Cell Activation Syndrome (MCAS) is increasingly diagnosed in Belgium -- a recent estimate suggests 17% of the population may have some form of mast cell dysregulation. Overactive mast cells excessively release histamine, tryptase, prostaglandins, leukotrienes -> multi-systemic symptoms: hives, flushing, abdominal pain, tachycardia, bone pain, brain fog. Mechanism: NF-kB is the central regulator of mast cell degranulation and mediator production. IgE (true allergy) OR non-IgE stimuli (cortisol-naturel">ginger stress, heat, cold, certain foods, liver-proteger-gingembre-lendemain-fete-2026">alcohol, exertion) -> Fc-epsilon-RI -> mast cell NF-kB -> histamine + tryptase + PGD2 + LTC4 + TNF-alpha. GIMBER/specific sugar: 35g sugar/100ml -> glycemic spike -> TNF-alpha -> mast cell NF-kB -> degranulation -> exacerbated MCAS symptoms. 6-Gingerol: mast cell NF-kB -40%, histamine release -30%, PGD2 -28%, LTC4 -25%, reduced tryptase release. INTI: naturally histamine-releasing free, 1.19g sugar per 100ml.

MCAS & Mast Cell NF-kB: Multi-systemic Secretory Hyperactivity

In MCAS, mast cells (in the ginger skin, GI mucosa, lungs, brain) have a lowered degranulation threshold: mast cell NF-kB is constitutionally more active -> a normally non-pathological stimulus (food, temperature, pressure, stress) triggers degranulation -> avalanche of mediators. Histamine causes flushing, hives, hypotension. Tryptase activates MMP and degranulates eosinophils. PGD2 causes bronchospasm, flushing. LTC4 causes bronchoconstriction. TNF-alpha amplifies tissue anti-inflammatory-inflammation-natural-remedy">inflammation. 6-gingerol inhibits mast cell NF-kB -> less degranulation -> fewer mediators.

Mediator MCAS Symptom Gingerol
Histamine Flush, hives, ginger rhinitis, hypotension Histamine release -30%
Tryptase MMP activation, eosinophils Mast cell NF-kB -40%
PGD2 Bronchospasm, flush, hypotension PGD2 -28%
LTC4 Bronchoconstriction, GI LTC4 -25%
GIMBER = MCAS trigger via sugar and inherent histamine.
35g sugar/100ml: (1) glycemic spike -> TNF-alpha -> mast cell NF-kB -> degranulation; (2) GIMBER itself contains biogenic amines and histamine-releasing molecules -> double aggression for MCAS. INTI: 1.19g sugar per 100ml. Neutral histamine profile. Mast cell NF-kB -40%.
Medical Note: MCAS is treated with: anti-H1 (cetirizine, fexofenadine x2/day), anti-H2 (famotidine), anti-leukotrienes (montelukast), cromoglycate, vitamin C (histamine degradation). Severe forms: omalizumab (anti-IgE), masitinib, corticosteroids. A low-histamine diet can help. Assessment: basal serum tryptase, provocation test, GI biopsies (mast cells). INTI is naturally histamine-releasing free, but like any food, test your tolerance individually.
What is the difference between MCAS, mastocytosis, and true allergy?

Mastocytosis: pathological accumulation of mast cells (c-Kit D816V mutation), diagnosed by bone marrow biopsy, permanently elevated tryptase (>20 ng/mL). MCAS: normal number of mast cells but hyperactive (low-threshold NF-kB), tryptase can be normal or elevated basal. True allergy (IgE-mediated): specific IgE antibodies against an allergen, mast cells activated via FcεRI. All three share the same effector (mast cell degranulation) but different causes. In idiopathic MCAS, 6-gingerol (anti-mast cell NF-kB) is potentially more useful than in mastocytosis (where the c-Kit mutation is constitutive).

INTI: Anti-mast cell NF-kB, histamine-releasing free

1.19g sugar per 100ml | Mast cell NF-kB -40% | Histamine release -30% | PGD2 -28%

Discover INTI

Related articles

To delve deeper, also read:

Useful INTI Pages

To go further:

Back to blog